|
rs4363657
|
|
|
0.020 |
GeneticVariation |
BEFREE |
<b>Aim:</b> To determine the association of serum creatine kinase (CK) and <i>SLCO1B1</i> rs4363657 polymorphism with statin-associated muscle adverse events (SAMAE) among dyslipidaemia participants.
|
31342800 |
2019 |
|
rs1265538677
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Dyslipidemia and TAFI Thr325Ile polymorphism were the main variables associated with recanalization resistance by the end of t-PA infusion: odds ratio (OR) 4.1 [95% confidence interval (95% CI) 1.6-10.8, P = 0.003] and OR 5.6 (95% CI 1.2-20, P = 0.031), respectively.
|
17723126 |
2007 |
|
rs751671151
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Dyslipidemia and TAFI Thr325Ile polymorphism were the main variables associated with recanalization resistance by the end of t-PA infusion: odds ratio (OR) 4.1 [95% confidence interval (95% CI) 1.6-10.8, P = 0.003] and OR 5.6 (95% CI 1.2-20, P = 0.031), respectively.
|
17723126 |
2007 |
|
rs2230808
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Dyslipidemia was observed in 10/13 (76.9%) patients with V8251 polymorphism vs. 27/37 (73%) of non-carriers, and in 16/21 (76.2%) patients with R1587K polymorphism vs. 21/29 (72.4%) in the remaining subjects.
|
19341173 |
2009 |
|
rs1232898090
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Pro12Ala polymorphism of PPAR(gamma2) gene is not associated with diabetic retinopathy but is associated with dyslipidemia in male type 2 diabetic patients.
|
11928067 |
2002 |
|
rs4880
|
|
|
0.020 |
GeneticVariation |
BEFREE |
ALA16VAL-MnSOD gene polymorphism and stroke: Association with dyslipidemia and glucose levels.
|
28552711 |
2017 |
|
rs1049353
|
|
|
0.010 |
GeneticVariation |
BEFREE |
G1359A Polymorphism of the Cannabinoid Receptor 1 Is Not Associated with Overweight and Dyslipidemia in Young Northeastern Mexicans.
|
31723535 |
2019 |
|
rs58542926
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A common non-synonymous polymorphism, E167K, in transmembrane six superfamily member 2 (TM6SF2) gene has been recently associated with an increased hepatic triglyceride content, dyslipidemia and liver fibrosis in NAFLD patients.
|
25581573 |
2015 |
|
rs6929846
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A multivariable logistic regression analysis adjusted for age, gender, body mass index, smoking status and the prevalence of diabetes mellitus revealed that rs6929846 of BTN2A1 was significantly (dominant model; P=2.4x10-4; odds ratio, 1.29) associated with dyslipidemia, with the minor T allele representing a risk for this condition.
|
24452779 |
2014 |
|
rs1260326
|
|
|
0.030 |
GeneticVariation |
BEFREE |
A polymorphism in the GCKR gene predicted dyslipidaemia (rs1260326, OR 1.15, 95% CI 1.09-1.22, p < 0.00001) but not the metabolic syndrome.
|
18853134 |
2008 |
|
rs3811381
|
|
|
0.010 |
GeneticVariation |
BEFREE |
After stratification according to risk factors, our analysis revealed a reduced frequency of the GG genotype of the Pro1827Arg polymorphism in patients with CAD and dyslipidemia vs the controls (p=0.031) and of the GG and LL genotypes in CAD patients with dyslipidemia vs CAD patients without dyslipidemia regarding the Pro1827Arg and CR1 HindIII intron 27 polymorphisms (GG, p=0.019; LL, p=0.184).
|
19578791 |
2009 |
|
rs429358
|
|
|
0.020 |
GeneticVariation |
BEFREE |
After taking into account confounding factors and correcting for multiple comparisons only APOE rs429358 and rs7412 variants remained significantly associated with risk of dyslipidemia.
|
26043189 |
2015 |
|
rs7412
|
|
|
0.010 |
GeneticVariation |
BEFREE |
After taking into account confounding factors and correcting for multiple comparisons only APOE rs429358 and rs7412 variants remained significantly associated with risk of dyslipidemia.
|
26043189 |
2015 |
|
rs11066782
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among six polymorphisms showing significant associations with dyslipidemia, the minor alleles of rs11066782 in KCTD10, rs11613718 in KCTD10 and rs11067233 in MMAB were significantly associated with a decreased risk of CHD (additive model: OR = 0.71, 95 % CI = 0.53-0.97, P = 0.029 for rs11066782; OR = 0.73, 95 % CI = 0.54-0.99, P = 0.044 for rs11613718 and OR = 0.57, 95 % CI = 0.40-0.80, P = 0.001 for rs11067233).
|
27716295 |
2016 |
|
rs11067233
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among six polymorphisms showing significant associations with dyslipidemia, the minor alleles of rs11066782 in KCTD10, rs11613718 in KCTD10 and rs11067233 in MMAB were significantly associated with a decreased risk of CHD (additive model: OR = 0.71, 95 % CI = 0.53-0.97, P = 0.029 for rs11066782; OR = 0.73, 95 % CI = 0.54-0.99, P = 0.044 for rs11613718 and OR = 0.57, 95 % CI = 0.40-0.80, P = 0.001 for rs11067233).
|
27716295 |
2016 |
|
rs11613718
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among six polymorphisms showing significant associations with dyslipidemia, the minor alleles of rs11066782 in KCTD10, rs11613718 in KCTD10 and rs11067233 in MMAB were significantly associated with a decreased risk of CHD (additive model: OR = 0.71, 95 % CI = 0.53-0.97, P = 0.029 for rs11066782; OR = 0.73, 95 % CI = 0.54-0.99, P = 0.044 for rs11613718 and OR = 0.57, 95 % CI = 0.40-0.80, P = 0.001 for rs11067233).
|
27716295 |
2016 |
|
rs3758539
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Analysis of 1489 subjects (26.9% HDL-C dyslipidemia) identified rs3758539, a non-coding variant in the 5'UTR of RBP4, to be associated with HDL-C dyslipidemia (odds ratio = 1.45, 95% confidence interval = 1.08-1.97, p = 0.01).
|
30497399 |
2018 |
|
rs10892151
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.
|
21939545 |
2011 |
|
rs512535
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ApoB rs512535 and ApoA1 rs670 major G allele homozygotes had increased MetS risk (OR 1.65 [CI 1.24, 2.20], P = 0.0006; OR 1.42 [CI 1.08, 1.87], P = 0.013), which may be, partly, explained by their increased abdominal obesity and impaired insulin sensitivity (P<0.05) but not dyslipidemia.
|
21122859 |
2011 |
|
rs670
|
|
|
0.030 |
GeneticVariation |
BEFREE |
ApoB rs512535 and ApoA1 rs670 major G allele homozygotes had increased MetS risk (OR 1.65 [CI 1.24, 2.20], P = 0.0006; OR 1.42 [CI 1.08, 1.87], P = 0.013), which may be, partly, explained by their increased abdominal obesity and impaired insulin sensitivity (P<0.05) but not dyslipidemia.
|
21122859 |
2011 |
|
rs429358
|
|
|
0.020 |
GeneticVariation |
BEFREE |
ApoE4 which differs from apoE3 by the single amino acid substitution Cys112Arg is also associated with dyslipidemia although binding of this isoform to the LDLR is unaffected.
|
25328986 |
2014 |
|
rs1057519655
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ApoE4 which differs from apoE3 by the single amino acid substitution Cys112Arg is also associated with dyslipidemia although binding of this isoform to the LDLR is unaffected.
|
25328986 |
2014 |
|
rs879254535
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ApoE4 which differs from apoE3 by the single amino acid substitution Cys112Arg is also associated with dyslipidemia although binding of this isoform to the LDLR is unaffected.
|
25328986 |
2014 |
|
rs599839
|
|
|
0.020 |
GeneticVariation |
BEFREE |
At 1p13.3, HV and CDCS participants carrying 1 or more rs599839 G allele had a lower prevalence of dyslipidemia (P ≤ 0.005) or lower levels of low-density lipoprotein (P=0.031) and total (P=0.004) cholesterol and/or less history of myocardial infarction (P ≤ 0.04) compared with AA participants.
|
21984477 |
2011 |
|
rs12953258
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Based on the logistic regression analysis, genotype CA and AA of rs12953258 were independent and risk factors for dyslipidemia in Uygur (CC vs CA; odds ratio = 1.48, 95% confidence interval = 1.11-1.98, P = 0.008), (CC vs AA; odds ratio = 2.48, 95% confidence interval1.07-5.79, P = 0.035).
|
25730073 |
2015 |